End-of-day quote
Korea S.E.
03:30:00 14/05/2024 am IST
|
5-day change
|
1st Jan Change
|
519
KRW
|
-2.81%
|
|
0.00%
|
-32.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
3,73,324
|
4,48,866
|
2,69,557
|
1,87,565
|
Enterprise Value (EV)
1 |
3,62,576
|
4,19,679
|
2,51,266
|
1,81,370
|
P/E ratio
|
-7.92
x
|
-18.8
x
|
-10.8
x
|
-7.66
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
219
x
|
157
x
|
316
x
|
81.7
x
|
EV / Revenue
|
213
x
|
147
x
|
295
x
|
79
x
|
EV / EBITDA
|
-19.4
x
|
-20.5
x
|
-11.4
x
|
-8.5
x
|
EV / FCF
|
-9.84
x
|
-24
x
|
-18.9
x
|
-24.8
x
|
FCF Yield
|
-10.2%
|
-4.18%
|
-5.28%
|
-4.03%
|
Price to Book
|
19.4
x
|
10.8
x
|
9.33
x
|
19.6
x
|
Nbr of stocks (in thousands)
|
23,829
|
24,351
|
29,332
|
30,799
|
Reference price
2 |
15,667
|
18,433
|
9,190
|
6,090
|
Announcement Date
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,705
|
2,861
|
851.8
|
2,296
|
EBITDA
1 |
-18,703
|
-20,482
|
-22,116
|
-21,343
|
EBIT
1 |
-21,666
|
-23,698
|
-25,133
|
-24,130
|
Operating Margin
|
-1,270.51%
|
-828.4%
|
-2,950.71%
|
-1,050.94%
|
Earnings before Tax (EBT)
1 |
-46,427
|
-24,579
|
-25,724
|
-24,752
|
Net income
1 |
-45,640
|
-24,183
|
-25,135
|
-24,168
|
Net margin
|
-2,676.37%
|
-845.35%
|
-2,950.84%
|
-1,052.59%
|
EPS
2 |
-1,978
|
-980.0
|
-851.0
|
-795.0
|
Free Cash Flow
1 |
-36,863
|
-17,522
|
-13,264
|
-7,302
|
FCF margin
|
-2,161.67%
|
-612.5%
|
-1,557.19%
|
-318.05%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
10,748
|
29,187
|
18,291
|
6,195
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-36,863
|
-17,522
|
-13,264
|
-7,302
|
ROE (net income / shareholders' equity)
|
585%
|
-79.3%
|
-70.1%
|
-126%
|
ROA (Net income/ Total Assets)
|
-30.4%
|
-24.1%
|
-27.5%
|
-42.5%
|
Assets
1 |
1,50,315
|
1,00,379
|
91,480
|
56,894
|
Book Value Per Share
2 |
809.0
|
1,710
|
985.0
|
310.0
|
Cash Flow per Share
2 |
1,258
|
1,997
|
293.0
|
425.0
|
Capex
1 |
784
|
2,156
|
1,124
|
157
|
Capex / Sales
|
45.98%
|
75.38%
|
132.01%
|
6.82%
|
Announcement Date
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
|
1st Jan change
|
Capi.
|
---|
| -32.95% | 1.32Cr | | +7.52% | 11TCr | | +11.38% | 11TCr | | -12.64% | 2.22TCr | | +0.44% | 2.13TCr | | -4.18% | 1.9TCr | | -37.85% | 1.85TCr | | -8.58% | 1.68TCr | | +37.41% | 1.25TCr | | -23.95% | 808.97Cr |
Bio Therapeutic Drugs
|